D-Day For IDEAYA - IDE397 Data To Be Unveiled Tomorrow

IDEAYA Biosciences Inc. (IDYA) is scheduled to release a clinical data update from the dose expansion cohort of its phase II trial of IDE397 as monotherapy in MTAP-deletion urothelial and non-small cell lung cancer patients tomorrow, i.e., July 8, 2024, before market open.

from RTT - Top Story https://ift.tt/uZ1lsfC
via IFTTT